Tagged with P

Country Manager Executive recruitment firms in various countries shared their take on the following five key strengths for anyone looking to become a pharma country manager. Click the link after each quote to view the recruitment firm’s full article.   1. Creativity in taking on new challenges “We need to check if…

CRO Katie Lai, associate director of Medpace Taiwan, introduces the company’s history in Taiwan and highlights the CRO’s unique service offering as a partner of choice to the biotech sector. Lai goes on to give her expert insights in the evolving clinical research environment of Taiwan and the APAC region.  …

Puerto Rico Lcdo. Juan Santiago – EIT, President of the Colegio de Químicos Puerto Rico, explains the far-reaching role of chemists in Puerto Rico’s industry, their current challenges and the goal of making chemistry appealing for the younger generations.   The ultimate objective is to contribute to the economic and social development…

Opinion Emanuele Ostuni, head of cell & gene therapy for Novartis Oncology in Europe, outlines how stakeholders across the biopharmaceutical value chain can surf the wave of innovation that breakthrough therapies such as CAR-T represent. Waves and Innovation CAR-T therapies are the frontrunners of a wave of amazing biomedical innovation Over…

USA In the face of rising costs in American healthcare, Carla Smith outlines five ways in which the US can improve the financial sustainability of its healthcare system.   Let’s take advantage of systems-level expertise and change our reality for the better In the United States, 18 percent of the gross…

Sweden   As one of few Swedish companies, Uppsala-based Orexo has made the leap to commercialize its star product for treating opioid addiction in the US, even before entering the European market. In this interview, CEO Nikolaj Sørensen highlights the impact of Orexo in finding solutions to tackle the US opioid…

Taiwan Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the island’s life sciences sector forward.   Johnsee Lee – Chairman, Taiwan Bio Industry Organization Dr Johnsee Lee holds a number…

Germany Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to bolster its development pipeline and create transformative biotechnological solutions.   German pharmaceutical company Bayer AG is setting its sights on…

China Dr. Chris Lu, CEO and cofounder of Laekna Therapeutics, shares Laekna’s ambition to deliver cures and improve the quality of life of patients globally, captured by the word ‘Laekna’, which is Old Norse for ‘to cure, to heal’. He also outlines Laekna’s focus on disease biology, specifically the areas of…

Sweden BioArctic is a Swedish biopharma company with the vision to become a world-leader in the research and development of disease-modifying treatments for patients with neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, and pioneering treatment methods for complete spinal cord injuries. Gunilla Osswald, CEO, explains how BioArctic is uniquely…

Puerto Rico Ricardo Zayas of US manufacturer Romark, highlights the company’s ambition to make Puerto Rico its operations and manufacturing headquarters. Currently in the scale-up phase, Zayas aims to expand the capacities of the plant in Manatí and position Romark as the poster child for new pharmaceutical manufacturers coming to Puerto Rico.…

Sweden Orifarm is the largest supplier of parallel imported medicines in the EU and a fast-growing supplier of generic pharmaceuticals in the Nordic countries. Christian Vallentin, country manager of Orifarm Sweden, explains the intricacies of the parallel import business and generics market in Sweden, how to successfully compete in both areas,…